Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung CancerHiroyuki Yasuda, Daniel B. Costa, Cai-Hong Yun et al.|Science Translational Medicine|2013Cited by 565
Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancerNorihiro Yamaguchi, Daniel B. Costa|Lung Cancer|2013Cited by 93